Depreciation of Niagen Bioscience, Inc. from 01 Jan 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Niagen Bioscience, Inc. annual and quarterly Depreciation in USD history and change rate from 01 Jan 2011 to 31 Dec 2025.
  • Niagen Bioscience, Inc. Depreciation for the quarter ending 31 Mar 2025 was $158,000, a 11% decline year-over-year.
  • Niagen Bioscience, Inc. annual Depreciation for 2025 was $612,000, a 7.7% decline from 2024.
  • Niagen Bioscience, Inc. annual Depreciation for 2024 was $663,000, a 24% decline from 2023.
  • Niagen Bioscience, Inc. annual Depreciation for 2023 was $870,000, a 0.12% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Niagen Bioscience, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $612,000 -$51,000 -7.7% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $663,000 -$207,000 -24% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $870,000 +$1,000 +0.12% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 $869,000 -$21,000 -2.4% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
2021 $890,000 +$19,000 +2.2% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023 2022 FY
2020 $871,000 +$109,000 +14% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022 2021 FY
2019 $762,000 +$155,000 +26% 01 Jan 2019 31 Dec 2019 10-K 12 Mar 2021 2020 FY
2018 $607,000 +$97,000 +19% 31 Dec 2017 31 Dec 2018 10-K 10 Mar 2020 2019 FY
2017 $510,000 +$178,266 +54% 01 Jan 2017 30 Dec 2017 10-K 07 Mar 2019 2018 FY
2016 $331,734 +$46,198 +16% 03 Jan 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
2015 $285,536 +$62,815 +28% 04 Jan 2015 02 Jan 2016 10-K 15 Mar 2018 2017 FY
2014 $222,721 -$23,454 -9.5% 29 Dec 2013 03 Jan 2015 10-K 16 Mar 2017 2016 FY
2013 $246,175 -$81,924 -25% 30 Dec 2012 28 Dec 2013 10-K 17 Mar 2016 2015 FY
2012 $328,099 -$533 -0.16% 01 Jan 2012 29 Dec 2012 10-K 27 Mar 2014 2013 FY
2011 $328,632 +$14,855 +4.7% 02 Jan 2011 31 Dec 2011 10-K 29 Mar 2013 2012 FY
2010 $313,777 03 Jan 2010 01 Jan 2011 10-K 15 Mar 2012 2011 FY

Niagen Bioscience, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $158,000 -$20,000 -11% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $178,000 -$50,000 -22% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $228,000 +$27,000 +13% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $201,000 -$20,000 -9% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $221,000 +$7,000 +3.3% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $214,000 +$41,000 +24% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $173,000 +$52,000 +43% 01 Jan 2019 31 Mar 2019 10-Q 18 May 2020 2020 Q1
Q1 2018 $121,000 -$8,000 -6.2% 31 Dec 2017 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $129,000 +$46,494 +56% 01 Jan 2017 01 Apr 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $82,506 +$15,604 +23% 03 Jan 2016 02 Apr 2016 10-Q 11 May 2017 2017 Q1
Q1 2015 $66,902 +$15,983 +31% 03 Jan 2015 04 Apr 2015 10-Q 12 May 2016 2016 Q1
Q1 2014 $50,919 -$28,265 -36% 29 Dec 2013 29 Mar 2014 10-Q 14 May 2015 2015 Q1
Q1 2013 $79,184 -$6,238 -7.3% 30 Dec 2012 30 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $85,422 +$3,460 +4.2% 01 Jan 2012 31 Mar 2012 10-Q/A 05 Dec 2013 2013 Q1
Q1 2011 $81,962 03 Jan 2011 02 Apr 2011 10-Q 10 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.